Curious cows
Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Synlait (ASX:SM1) has warned its FY24 revenues will come in below its previously stated $45M – $60M guidance.

“Unforeseen” conditions associated with the year’s end also saw Synlait unable to offer investors an upgraded outlook at all on Wednesday.

A combination of internal reviews and initiatives, coupled with what the company described as manufacturing and shipping problems, were ultimately pointed to as why the company couldn’t provide downgraded guidance.

“Synlait remains on track to meet its minimum adjusted EBITDA for FY24 for bank covenant purposes, as announced on 3 July 2024,” the company wrote at the end of its release on Wednesday.

It’s likely to be another blow for Synlait investors who maybe hoped FY24 could kick off a fresh page. One year returns are down -80% and YTD performance is down -66%.

SM1 last traded at 30cps.

SM1 by the numbers
More From The Market Online
The Market Online Video

ASX Market Close: Bourse finishes week on a high as Wisetech pummeled | November 22, 2024

The ASX200 closed up 0.85% at 8,393 points. Economists increasingly expect interest rates in Australia won’t…
The Market Online Video

HotCopper Highlights: Your most watched stocks for Week 47, 2024

In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing,…
Nuclear explosion mushroom cloud concept

Week 47 Wrap: HotCopper users’ most watched; Brent lifts on Putin’s scary letter; RFK dents CSL

Welcome to the end of another week. Let's start with what HotCopper users have been watching…
Dale Gillham's photo, and wording 'Words from Wealth Within's Chief Analyst Dale Gillham.

Dale Gillham’s weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in th…